Get Quote: JNJ
Financials: Latest Results
It's been a rough stretch of years for the multibillion dollar pharmaceutical company, which has just recently had a major leadership shake-up. Former CEO Bill Weldon announced in February that he would step down as CEO to be replaced by Alex Gorsky -- former vice chairman for J&J. The leadership change happened after a long series of recalls and lawsuits at J&J. Most recently, an Arkansas judge slapped the company with a $1.2 billion fine on charges that it engaged in dishonest marketing practices of the antipsychotic drug Risperdal. |
Industry: Pharmaceuticals
|
| Rank # of Fortune 500 Companies | |
|---|---|
| California | 53 |
| Texas | 52 |
| New York | 50 |
| Company | Rank |
|---|---|
| 73 | |
| NetApp | 474 |
| NuStar Energy | 377 |